| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/17/2013 | EP2614835A1 Vaccination with multiple clades of H5 influenza A virus |
| 07/17/2013 | EP2614834A1 Compositions and methods for the prevention and treatment of autoimmune conditions |
| 07/17/2013 | EP2614146A1 Ttll4 peptides and vaccines containing the same |
| 07/17/2013 | EP2614143A1 Immunotherapy of cancer using genetically engineered gd2-specific t cells |
| 07/17/2013 | EP2614140A2 Mdck-derived cell lines adapted to serum-free culture and suspension culture and method for preparing vaccine virus using the cells |
| 07/17/2013 | EP2614085A2 Anti-il-1 beta antibodies and methods of use |
| 07/17/2013 | EP2614084A2 Anti-human folate receptor beta antibodies and methods of use |
| 07/17/2013 | EP2614082A1 4-1bb binding molecules |
| 07/17/2013 | EP2614074A1 Methods and compositions involving protective staphylococcal antigens |
| 07/17/2013 | EP2614072A2 Human cytomegalovirus vaccine |
| 07/17/2013 | EP2613808A1 Companion animal treatments |
| 07/17/2013 | EP2613807A1 Foot and mouth disease virus with increased stability and its use as vaccine |
| 07/17/2013 | EP2613806A1 Non-lipidated variants of neisseria meningitidis orf2086 antigens |
| 07/17/2013 | EP2613805A2 Developments in meningococcal outer membrane vesicles |
| 07/17/2013 | EP2613804A1 Immunogenic composition comprising neisseria menigitidis macrophage infectivity potentiator protein |
| 07/17/2013 | EP2613803A1 Vaccine against n. meningitidis |
| 07/17/2013 | EP2613802A2 Environmental clostridial bacteriotherapy and related formulations and methods of manufacture and use |
| 07/17/2013 | EP2613801A2 Use of anti third party central memory t cells for anti-leukemia/lymphoma treatment |
| 07/17/2013 | EP2613629A1 Oral veterinary preparations |
| 07/17/2013 | EP2261380B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins |
| 07/17/2013 | CN1946421B Cancer treatment using viruses and camptothecins |
| 07/17/2013 | CN1568329B Immunogenic peptide composition for the prevention and treatment of Alzheimer's disease |
| 07/17/2013 | CN103209994A Antibodies useful in passive influenza immuization |
| 07/17/2013 | CN103209993A Monoclonal antibodies and detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid |
| 07/17/2013 | CN103209990A Recombinant hemagglutinin protein of influenza virus and vaccine containing the same |
| 07/17/2013 | CN103209708A Immunogenic compositions |
| 07/17/2013 | CN103209707A Viral vaccine and process for preparing the same |
| 07/17/2013 | CN103209706A Methods to produce bunyavirus replicon particles |
| 07/17/2013 | CN103209705A Drug and method for the prophylaxis of HIV infection and for the prophylaxis and treatment of diseases caused by or associated with HIV, including AIDS |
| 07/17/2013 | CN103209696A Methods of enhancing antibody-dependent cellular cytotoxicity |
| 07/17/2013 | CN103205460A Chimeric virus, and preparation method and application thereof |
| 07/17/2013 | CN103205436A Humanized immunoglobulin loci |
| 07/17/2013 | CN103205432A Disseminated superficial actinic porokeratosis (DSAP) related gene |
| 07/17/2013 | CN103205399A Recombinant herpes simplex virus, and preparation method and application thereof |
| 07/17/2013 | CN103204943A Fusion protein of RSV (respiratory syncytial virus) protein F and Fc, and application thereof |
| 07/17/2013 | CN103204942A Porcine circovirus type II gene engineering subunit vaccine, and preparation method and application thereof |
| 07/17/2013 | CN103204935A Modified Antigen Binding Molecules With Altered Cell Signaling Activity |
| 07/17/2013 | CN103204934A Cytotoxicity Mediation Of Cells Evidencing Surface Expression Of Cd44 |
| 07/17/2013 | CN103204933A High-stability human anti-VEGF (vascular endothelial growth factor) antibody and application thereof |
| 07/17/2013 | CN103204931A Human Monoclonal Antibodies To Fucosyl-gm1 And Methods For Using Anti-fucosyl-GM1 |
| 07/17/2013 | CN103204908A MTA1-derived anti-tumour CTL (cytotoxiclymphocyte) epitope peptide and application thereof |
| 07/17/2013 | CN103203028A Vaccine composition for improving immune protective rate of anti-Fasciola hepatica Cat L1 DNA, and preparation method thereof |
| 07/17/2013 | CN103203019A Multiple-variable Dose Regimen For Treating Tnfalpha-related Disorders |
| 07/17/2013 | CN103203018A Compound adjuvant for tuberculosis subunit vaccine, tuberculosis subunit vaccine from same and preparation method and application thereof |
| 07/17/2013 | CN103203017A Pharmaceutical Composition And Method For Producing The Same |
| 07/17/2013 | CN103203016A Cat Allergen Fusion Proteins And Uses Thereof |
| 07/17/2013 | CN103202828A Fish immersion immunization method |
| 07/17/2013 | CN103202809A 11S soybean antigen protein injection and preparation method thereof |
| 07/17/2013 | CN102533798B Recombinant denovirus for expressing foot-and-mouth disease virus type A empty capsid, and application thereof |
| 07/17/2013 | CN102499982B Method for producing trivalent inactivated vaccine against Haemophilus parasuis infection |
| 07/17/2013 | CN102488893B Duck hemorrhagic oophoritis inactivated vaccine production method by using cell line and product thereof |
| 07/17/2013 | CN102206276B Humanized antibodies derived from DD-3B6/22, specific for the D-dimer fragment of fibrin |
| 07/17/2013 | CN102125687B Production method for bivalent inactivated vaccine for infectious serositis of ducks |
| 07/17/2013 | CN101985037B Applications of receptor for activated C-kinase 1 as target against tumor drug-resistance |
| 07/17/2013 | CN101903514B Peptides that can bind to scurfin and uses thereof |
| 07/17/2013 | CN101903404B Bivalent, bispecific antibodies |
| 07/17/2013 | CN101795709B Multimeric multiepitope influenza vaccines |
| 07/17/2013 | CN101646418B Compositions and methods for modulating immune responses |
| 07/17/2013 | CN101626784B Treatment and/or prevention of non-infectious medical conditions using antibody-containing compositions |
| 07/17/2013 | CN101575361B Novel specific polypeptide and application thereof in preparing medicament for diagnosing, preventing and treating severe acute respiratory syndrome caused by coronaviruses |
| 07/17/2013 | CN101472943B SPARC-derived cancer rejection antigen peptide and pharmaceutical comprising the same |
| 07/17/2013 | CN101379086B Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8-associated disorders |
| 07/17/2013 | CN101247827B Vaccine production process |
| 07/17/2013 | CN101222926B Methods and compositions for treating or preventing cancer |
| 07/17/2013 | CN101184506B Methods and compositions for modulating hyperstabilized c-met |
| 07/17/2013 | CN101087886B Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof |
| 07/16/2013 | US8487088 RNA interference suppression of neurodegenerative diseases and methods of use thereof |
| 07/16/2013 | US8487082 Synthetic scFv analogue to the 6313/G2 (anti angiotensin II type 1 receptor) monoclonal antibody variable regions |
| 07/16/2013 | US8487081 Antibodies specific for human hepcidin |
| 07/16/2013 | US8486908 Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response |
| 07/16/2013 | US8486895 Anti-epidermal growth factor receptor antibodies and uses thereof |
| 07/16/2013 | US8486893 Treatment of conditions involving demyelination |
| 07/16/2013 | US8486886 Botulinum toxin treatments |
| 07/16/2013 | US8486685 Cellular permissivity factor for viruses and uses thereof |
| 07/16/2013 | US8486465 Therapeutic nerium oleander extract compositions and methods of using |
| 07/16/2013 | US8486422 Methods of activating clostridial toxins |
| 07/16/2013 | US8486421 Antigen-norovirus P-domain monomers and dimers, antigen-norovirus P-particle molecules, and methods for their making and use |
| 07/16/2013 | US8486420 Modified Rna virus packaged with structural proteins and second virus; induce immunology response |
| 07/16/2013 | US8486419 Flavivirus mutant has a deletion in the capsid protein of at least more than 4 successive amino acids, wherein the carboxy terminal hydrophobic region is not affected by the deletion |
| 07/16/2013 | US8486418 Recombinant avian paramyxovirus vaccine and method for making and using thereof |
| 07/16/2013 | US8486417 Recombinant bicistronic Flavivirus vectors |
| 07/16/2013 | US8486416 Use of SDF-1 to improve ischemic myocardial function |
| 07/16/2013 | US8486414 Immunogenic compositions comprising Mycobacterium tuberculosis polypeptides and fusions thereof |
| 07/16/2013 | US8486411 Methods for identifying an epitope of a polypeptide, chlamydial antigenic polypeptides identified thereby, and methods of use thereof |
| 07/16/2013 | US8486410 RLIP76 liposomes for protection against irradiation |
| 07/16/2013 | US8486409 Alpha-emitting constructs and uses thereof |
| 07/16/2013 | US8486408 Methods for the treatment of graft-versus-host disease |
| 07/16/2013 | US8486407 Methods for the treatment or prevention of systemic sclerosis |
| 07/16/2013 | US8486406 Monoclonal antibodies as a medicament for the therapeutic and/or prophylactic treatment of swine-origin influenza A (H1N1) virus (S-OIV) infections |
| 07/16/2013 | US8486405 Method for diagnosing and treating emphysema |
| 07/16/2013 | US8486404 Antibody specifically binding to angiopoietin-2 and use thereof |
| 07/16/2013 | US8486403 Method of promoting bone growth by an anti-activin A antibody |
| 07/16/2013 | US8486401 Monoclonal antibodies binding to TrkA and acting as NGF-antagonist molecules and their use for treating pain induced by NGF |
| 07/16/2013 | US8486400 Methods of inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling |
| 07/16/2013 | US8486398 Anticoagulant antidotes comprising antibodies that bind dabigatran and/or related compounds |
| 07/16/2013 | US8486397 Anti-VEGF-C antibodies and methods using same |
| 07/16/2013 | US8486396 Compositions and methods for diagnosing and treating an inflammation |
| 07/16/2013 | US8486395 Anti-CD19 antibodies |
| 07/16/2013 | US8486394 Generation and Profiling of fully human hucal gold-derived therapeutic antibodies specific for human CD38 |
| 07/16/2013 | US8486393 Monoclonal antibodies for CSPG4 for the diagnosis and treatment of basal breast carcinoma |